293 related articles for article (PubMed ID: 20124097)
1. A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.
Chentoufi AA; Dasgupta G; Christensen ND; Hu J; Choudhury ZS; Azeem A; Jester JV; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2010 Mar; 184(5):2561-71. PubMed ID: 20124097
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
3. Human Asymptomatic Epitope Peptide/CXCL10-Based Prime/Pull Vaccine Induces Herpes Simplex Virus-Specific Gamma Interferon-Positive CD107
Khan AA; Srivastava R; Vahed H; Roy S; Walia SS; Kim GJ; Fouladi MA; Yamada T; Ly VT; Lam C; Lou A; Nguyen V; Boldbaatar U; Geertsema R; Fraser NW; BenMohamed L
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899087
[TBL] [Abstract][Full Text] [Related]
4. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.
Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469
[TBL] [Abstract][Full Text] [Related]
5. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
6. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.
Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359
[TBL] [Abstract][Full Text] [Related]
7. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
[TBL] [Abstract][Full Text] [Related]
8. Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?
Dasgupta G; BenMohamed L
Vaccine; 2011 Aug; 29(35):5824-36. PubMed ID: 21718746
[TBL] [Abstract][Full Text] [Related]
9. HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.
Srivastava R; Khan AA; Spencer D; Vahed H; Lopes PP; Thai NT; Wang C; Pham TT; Huang J; Scarfone VM; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2015 Mar; 194(5):2232-48. PubMed ID: 25617474
[TBL] [Abstract][Full Text] [Related]
10. Blockade of LAG-3 Immune Checkpoint Combined With Therapeutic Vaccination Restore the Function of Tissue-Resident Anti-viral CD8
Roy S; Coulon PG; Srivastava R; Vahed H; Kim GJ; Walia SS; Yamada T; Fouladi MA; Ly VT; BenMohamed L
Front Immunol; 2018; 9():2922. PubMed ID: 30619285
[TBL] [Abstract][Full Text] [Related]
11. Dok-1 and Dok-2 Are Required To Maintain Herpes Simplex Virus 1-Specific CD8
Lahmidi S; Yousefi M; Dridi S; Duplay P; Pearson A
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490594
[TBL] [Abstract][Full Text] [Related]
12. Human Epitopes Identified from Herpes Simplex Virus Tegument Protein VP11/12 (UL46) Recall Multifunctional Effector Memory CD4
Srivastava R; Coulon PA; Prakash S; Dhanushkodi NR; Roy S; Nguyen AM; Alomari NI; Mai UT; Amezquita C; Ye C; Maillère B; BenMohamed L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915285
[TBL] [Abstract][Full Text] [Related]
13. The role of a glycoprotein K (gK) CD8+ T-cell epitope of herpes simplex virus on virus replication and pathogenicity.
Mott KR; Chentoufi AA; Carpenter D; BenMohamed L; Wechsler SL; Ghiasi H
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2903-12. PubMed ID: 19168902
[TBL] [Abstract][Full Text] [Related]
14. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.
Chentoufi AA; Zhang X; Lamberth K; Dasgupta G; Bettahi I; Nguyen A; Wu M; Zhu X; Mohebbi A; Buus S; Wechsler SL; Nesburn AB; BenMohamed L
J Immunol; 2008 Jan; 180(1):426-37. PubMed ID: 18097044
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.
Dervillez X; Qureshi H; Chentoufi AA; Khan AA; Kritzer E; Yu DC; Diaz OR; Gottimukkala C; Kalantari M; Villacres MC; Scarfone VM; McKinney DM; Sidney J; Sette A; Nesburn AB; Wechsler SL; BenMohamed L
J Immunol; 2013 Nov; 191(10):5124-38. PubMed ID: 24101547
[TBL] [Abstract][Full Text] [Related]
16. Bolstering the Number and Function of HSV-1-Specific CD8
Khan AA; Srivastava R; Chentoufi AA; Kritzer E; Chilukuri S; Garg S; Yu DC; Vahed H; Huang L; Syed SA; Furness JN; Tran TT; Anthony NB; McLaren CE; Sidney J; Sette A; Noelle RJ; BenMohamed L
J Immunol; 2017 Jul; 199(1):186-203. PubMed ID: 28539429
[TBL] [Abstract][Full Text] [Related]
17. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice.
Gmyrek GB; Filiberti A; Montgomery M; Chitrakar A; Royer DJ; Carr DJJ
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999018
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
Frye TD; Chiou HC; Hull BE; Bigley NJ
Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
[TBL] [Abstract][Full Text] [Related]
19. The Herpes Simplex Virus Latency-Associated Transcript Gene Is Associated with a Broader Repertoire of Virus-Specific Exhausted CD8+ T Cells Retained within the Trigeminal Ganglia of Latently Infected HLA Transgenic Rabbits.
Srivastava R; Dervillez X; Khan AA; Chentoufi AA; Chilukuri S; Shukr N; Fazli Y; Ong NN; Afifi RE; Osorio N; Geertsema R; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2016 Apr; 90(8):3913-3928. PubMed ID: 26842468
[TBL] [Abstract][Full Text] [Related]
20. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.
Royer DJ; Gurung HR; Jinkins JK; Geltz JJ; Wu JL; Halford WP; Carr DJJ
J Virol; 2016 Jun; 90(11):5514-5529. PubMed ID: 27030264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
